ClinicalTrials.gov record
Completed Phase 3 Interventional

A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)

ClinicalTrials.gov ID: NCT03398005

Public ClinicalTrials.gov record NCT03398005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 1:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-center, Placebo-controlled, Randomized, Double-blind 26-week Study to Assess the Safety and Efficacy of CaPre® in Patients With Severe Hypertriglyceridemia.

Study identification

NCT ID
NCT03398005
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Grace Therapeutics Inc.
Industry
Enrollment
256 participants

Conditions and interventions

Interventions

  • CaPre Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2018
Primary completion
Jul 20, 2019
Completion
Nov 19, 2019
Last update posted
Jan 17, 2020

2018 – 2019

United States locations

U.S. sites
69
U.S. states
26
U.S. cities
60
Facility City State ZIP Site status
Research site Birmingham Alabama 35242
Research site Tucson Arizona 85712
Research site Conway Arkansas 72034
Research site El Cajon California 92020
Research site Fresno California 93702
Research site Garden Grove California 92844
Research site Lomita California 90717
Research site Newport Beach California 92663
Research site Tustin California 92780
Research site Boca Raton Florida 33487
Research site Clearwater Florida 33765
Research site Fort Myers Florida 33912
Research site Hialeah Florida 33012
Research site Homestead Florida 33030
Research site Jacksonville Florida 32256
Research site Kendall Florida 33175
Research site Lake Worth Florida 33461
Research site Miami Florida 33125
Research site Miami Florida 33126
Research site Miami Florida 33135
Research site Miami Florida 33144
Research site Miami Florida 33155
Research site Miami Florida 33165
Research site Miami Florida 33173
Research site Miami Springs Florida 33166
Research site North Miami Beach Florida 33162
Research site Orlando Florida 32825
Research site Pembroke Pines Florida 33026
Research site Tamarac Florida 33321
Research site Tampa Florida 33603
Research site Wellington Florida 33449
Research site West Palm Beach Florida 33401
Research site West Palm Beach Florida 33409
Research site Atlanta Georgia 30345
Research site Gainesville Georgia 30501
Research site Savannah Georgia 31406
Research site Snellville Georgia 30078
Research site Sugar Hill Georgia 30518
Research site Meridian Idaho 83642
Research site Meridian Idaho 83646
Research site Gurnee Illinois 60031
Research site Anderson Indiana 46011
Research site Louisville Kentucky 40213
Research site Eunice Louisiana 70535
Research site Cadillac Michigan 49601
Research site Jackson Mississippi 39202
Research site Olive Branch Mississippi 38654
Research site St Louis Missouri 63117
Research site Omaha Nebraska 68114
Research site Greensboro North Carolina 27408
Research site Mooresville North Carolina 28117
Research site Canton Ohio 44710
Research site Marion Ohio 43302
Research site Maumee Ohio 43537
Research site Norman Oklahoma 73069
Research site Beaver Pennsylvania 15009
Research site Spartanburg South Carolina 29301
Research site Chattanooga Tennessee 37421
Research site Memphis Tennessee 38119
Research site Arlington Texas 76012
Research site Houston Texas 77084
Research site Houston Texas 77089
Research site Lampasas Texas 76550
Research site San Antonio Texas 78258
Research site Salt Lake City Utah 84107
Research site West Jordan Utah 84088
Research site Danville Virginia 24541
Research site Bellevue Washington 98007
Research site Kenosha Wisconsin 53144

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03398005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2020 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03398005 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →